Jefferies Initiates Coverage On PMV Pharma with Buy Rating, Announces Price Target of $5
Benzinga Newsdesk 2 years ago
NewsPrice TargetInitiationAnalyst Ratings
Jefferies analyst Kambiz Yazdi initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target of $5.
Jefferies analyst Kambiz Yazdi initiates coverage on PMV Pharma (NASDAQ:PMVP) with a Buy rating and announces Price Target of $5.